Recently there is an increased interest in developing magnetic semiconductors due to their promising applications in spintronics. The semiconductors can be made ferromagnetic by doping with transition-metal ions. In this paper, the results of our studies using x-ray diffraction (XRD) and IR and Raman spectroscopic techniques on the effect of Fe doping on the structural properties of SnO2 are presented. The XRD results showed that the doping affects the structure and the lattice constants decrease as doping concentration increases, reaches a minimum, and again increases. The doped samples are under compressive strain and the strain is maximum for the sample doped with 3% (at. %) Fe. The grain size of the nanoparticles decreases from 42nm in undoped SnO2 to 26nm in Sn0.90Fe0.10O2. It was observed that the preferred orientation is along the (101) direction and both texture coefficient and preferential orientation show a dependence on doping level. The Raman spectra showed clear evidences of the change in grain size and incorporation of Fe into the crystal lattice. The Raman bands observed in the 700cm−1 region are assigned to the vibrational local modes of the Fe3+ ions which are occupying the sites of Sn4+ ions. The intensities of the Raman bands showed a strong dependence on the doping concentration. The decrease in intensity of the Sn–O symmetric stretching band at 630cm−1 for higher doping concentrations is explained to be due to the decrease in grain size. A striking correlation is found between the Fe Raman mode intensities and the ferromagnetic magnetization of Sn1−xFexO2, suggesting that the ferromagnetic behavior results from Fe3+ ions incorporated in the host SnO2 lattice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.